tiprankstipranks
Trending News
More News >
Aim Immunotech Inc. (AIM)
XASE:AIM
US Market

AIM ImmunoTech (AIM) Income Statement

Compare
926 Followers

AIM ImmunoTech Income Statement

Last quarter (Q3 2025), AIM ImmunoTech's total revenue was $26.00K, a decrease of -25.71% from the same quarter last year. In Q3, AIM ImmunoTech's net income was $-3.28M. See AIM ImmunoTech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 170.00K$ 202.00K$ 141.00K$ 135.00K$ 163.00K
Gross Profit
$ 139.00K$ 160.00K$ 565.00K$ -715.00K$ -643.00K
Operating Expenses
$ 19.91M$ 32.08M$ 20.49M$ 18.12M$ 14.51M
Depreciation and Amortization
$ 246.00K$ 238.00K$ -424.00K$ 775.00K$ 733.00K
EBITDA
$ -16.49M$ -28.72M$ -19.87M$ -18.29M$ -12.99M
Operating Income
$ -19.77M$ -31.92M$ -19.92M$ -18.84M$ -15.15M
Other Income/Expenses
$ 2.45M$ 2.95M$ 477.81K$ -289.00K$ 752.00K
Pretax Income
$ -17.32M$ -28.96M$ -19.45M$ -19.13M$ -14.40M
Net Income
$ -17.32M$ -28.96M$ -19.45M$ -19.13M$ -14.40M
Per Share Metrics
Basic EPS
$ -0.31$ -0.60$ -0.44$ -0.45$ -0.51
Diluted EPS
$ -0.31$ -0.60$ -0.44$ -0.45$ -0.51
Weighted Average Shares Outstanding
-----
Weighted Average Shares Outstanding (Diluted)
-----
Currency in USD

AIM ImmunoTech Earnings and Revenue History